GeneOne Life Science, Inc. (KRX:011000)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,070.00
-35.00 (-1.66%)
At close: Mar 21, 2025, 3:30 PM KST

GeneOne Life Science Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
35,72040,20348,71838,70041,503
Upgrade
Other Revenue
00--0-
Upgrade
Revenue
35,72040,20348,71838,70041,503
Upgrade
Revenue Growth (YoY)
-11.15%-17.48%25.89%-6.75%0.63%
Upgrade
Cost of Revenue
46,68748,08839,54130,05830,211
Upgrade
Gross Profit
-10,967-7,8859,1778,64211,292
Upgrade
Selling, General & Admin
20,80426,62730,86721,49819,651
Upgrade
Research & Development
3,5567,04312,14711,4418,396
Upgrade
Other Operating Expenses
503.5432.8295.42223.23160.42
Upgrade
Operating Expenses
32,07240,48349,37636,17029,821
Upgrade
Operating Income
-43,039-48,368-40,199-27,527-18,529
Upgrade
Interest Expense
-2,156-1,180-7,309-4,455-628.5
Upgrade
Interest & Investment Income
125.18518.686,2161,538561.22
Upgrade
Currency Exchange Gain (Loss)
-248.79107.21278.954,361-2,424
Upgrade
Other Non Operating Income (Expenses)
-3,4333,5692,9589,6382,791
Upgrade
EBT Excluding Unusual Items
-48,751-45,353-38,056-16,445-18,230
Upgrade
Gain (Loss) on Sale of Investments
-4.254.25---
Upgrade
Gain (Loss) on Sale of Assets
2.823.41.31-106.933.24
Upgrade
Asset Writedown
--32,309---
Upgrade
Other Unusual Items
---1,018-
Upgrade
Pretax Income
-48,753-77,655-38,054-15,534-18,226
Upgrade
Income Tax Expense
-216.19113.4595.79353.75421.99
Upgrade
Net Income
-48,537-77,768-38,150-15,888-18,648
Upgrade
Net Income to Common
-48,537-77,768-38,150-15,888-18,648
Upgrade
Shares Outstanding (Basic)
7978777460
Upgrade
Shares Outstanding (Diluted)
7978777460
Upgrade
Shares Change (YoY)
2.15%0.36%4.37%22.98%88.03%
Upgrade
EPS (Basic)
-611.00-1000.00-492.35-214.00-308.90
Upgrade
EPS (Diluted)
-611.00-1000.00-492.35-214.00-309.00
Upgrade
Free Cash Flow
-19,356-27,345-69,419-87,291-32,069
Upgrade
Free Cash Flow Per Share
-243.66-351.62-895.90-1175.77-531.20
Upgrade
Gross Margin
-30.70%-19.61%18.84%22.33%27.21%
Upgrade
Operating Margin
-120.49%-120.31%-82.51%-71.13%-44.65%
Upgrade
Profit Margin
-135.88%-193.44%-78.31%-41.05%-44.93%
Upgrade
Free Cash Flow Margin
-54.19%-68.02%-142.49%-225.56%-77.27%
Upgrade
EBITDA
-25,078-35,592-34,776-22,877-14,508
Upgrade
EBITDA Margin
-70.21%-88.53%-71.38%-59.11%-34.96%
Upgrade
D&A For EBITDA
17,96112,7765,4244,6504,021
Upgrade
EBIT
-43,039-48,368-40,199-27,527-18,529
Upgrade
EBIT Margin
-120.49%-120.31%-82.51%-71.13%-44.65%
Upgrade
Advertising Expenses
381.32196.96341.71194.45168.08
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.